Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Tang W, Ren L, Liu T, Ye Q, et al. Bevacizumab Plus mFOLFOX6 Versus mFOLFOX6 Alone as First-Line Treatment for RAS Mutant Unresectable Colorectal Liver-Limited Metastases: The BECOME Randomized Controlled Trial. J Clin Oncol 2020;38:3175-3184.
PMID: 32749938


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016